-FirstPost.com Not all U-turns are bad. Some are good, like the one by the NDA government on the MNREGA, also called NREGA . For the uninitiated, the new NDA government had about three months back proposed to make changes to the pro-poor scheme launched by the erstwhile United Progressive Alliance. According to media reports that cited a circular, the proposal was to amend the NREG Act by restricting the area of work...
More »SEARCH RESULT
Contract farming silence in farm bill -Sambit Saha
-The Telegraph Calcutta: Private companies will be able to buy farm produce directly from farmers in Bengal. But the widely-anticipated whoop of exultation from Indian industry over the amendment in the state's agri-marketing act was somewhat muted because of the lack of clarity on the issue of contract farming and the absence of clear guidelines on whether the state government would provide incentives and help in the acquisition of land for private...
More »Keep kerosene subsidy: CPI
-The Hindu Terming the move to scrap the kerosene subsidy "a shameless attack on the poor and downtrodden," the CPI demanded that the subsidy on the fuel remain. On Friday, The Hindu reported that the Finance Ministry was planning to take forward the previous government's policy of phasing out subsidised kerosene. "Gas supply is very inadequate and sold in black markets. Some States becoming 100 per cent electrified and kerosene-free is a big...
More »'Scaling back NREGA would force rural youth to move to bigger cities' -Sameer Arshad
-The Times of India NEW DELHI: Mangal Singh's three sons were forced to work as daily wage labourers in Gujarat, hundreds of kilometres from their village in Rajasthan's Ajmer district, before the National Rural Employment Guarantee Act (NREGA) was introduced. They were employed there for perilous digging of wells and stayed away from their home for months leaving their 82-year-old father to fend for himself. The NREGA came as a big boon for...
More »MNCs deprive India of vital drugs -Rupali Mukherjee
-The Times of India MUMBAI: Some multinational companies (MNCs) have been delaying the launch of life-saving drugs in India years after getting monopoly rights, while cheaper generic versions of exorbitantly-priced medicines are going off the shelves under the product patenting law. Corporates such as Japanese firm Otsuka Pharmaceuticals, US-based Bristol Myers-Squibb (BMS) and Swiss firm Novartis are deferring the launch of medicines critical for treatment of serious non-communicable diseases like cancer, HIV,...
More »